ScopeNovo: a De Novo Peptide Sequencing Method Using Spectrum-Spectrum Similarity to Refine the Prediction Accuracy

Clicks: 8
ID: 332413
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #922 of 953 articles by views in BMC Bioinformatics

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 953 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Motivation De novo peptide sequencing from tandem mass spectra is essential for characterizing unknown proteins, identifying novel post-translational modifications, and analyzing samples without reference databases. While recent deep learning models have improved the predicted peptide accuracy, they typically select the predicted peptide sequence based solely on sequence-level decoding scores. Very often, high scores are assigned to peptides without the direct support from the observed mass spectrum. Results We present ScopeNovo, a de novo peptide sequencing method that improves predicted peptide accuracy by using spectrum-spectrum similarity between the input spectrum and the “representative” spectrum corresponding to the predicted peptide sequence. ScopeNovo generates multiple candidate peptides using an existing peptide de novo sequencing learning model and reranks candidates based on spectrum-spectrum similarity. To test our method, we use π-PrimeNovo as the base learning model. Experimental results on the standard nine-species benchmark datasets V1 and V2 show that ScopeNovo can substantially improve the prediction accuracy. We designed two settings, where Setting 1 is for well-annotated species, and Setting 2 is for species that are not well annotated. For Setting 1, ScopeNovo improves the average peptide accuracies of π-PrimeNovo over the nine species by 6.1% and 4.0% on V1 and V2, respectively. For Setting 2, ScopeNovo can still improve the peptide accuracy of π-PrimeNovo over the nine species by 3.4% and 1.9% on the V1 and V2 benchmark datasets, respectively. Compared to the best known method, RankNovo, the peptide accuracies over the nine species on V1 and V2 of our method for Setting 1 are 0.711 and 0.737, where the peptide accuracies for RankNovo are 0.687 and 0.682. Even for Setting 2, the peptide accuracies of our method are comparable to those of RankNovo. Availability ScopeNovo is implemented in Python under an MIT license. The source code is freely available at https://github.com/SoSongzhi/ScopeNovo.git. The test data are available at https://doi.org/10.5281/zenodo.23181841. Supplementary information Supplementary data are available at Bioinformatics online.
Reference Key
openalex_W7220676429 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Zhi Song, Zejian Ding, Lusheng Wang
Journal BMC Bioinformatics
Year 2026
DOI
10.1093/bioinformatics/btag755
URL
https://doi.org/10.1093/bioinformatics/btag755
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.